 |
Volcano to Highlight its Leadership in Precision Guided Therapy at EuroPCR 2012
May 14, 2012
|
13.1 KB |
|
| |
SAN DIEGO, May 14, 2012 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC) today announced its plans to highlight its extensive product portfolio, strong product pipeline, and presentations on Fractional Flow Reserve (FFR) and Instant Wave-Free Ratio™ Functionality (iFR™) at EuroPCR 2012, a major cardiology meeting being held in Paris f...
|
|
Volcano Corporation Presentation At JMP Securities Conference To Be Webcast
May 7, 2012
|
9.0 KB |
|
| |
SAN DIEGO, May 7, 2012 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that it will be participating in the 11th Annual JMP Securities Research Conference on Monday, May 1...
|
|
Volcano Corporation Presentation At Deutsche Bank Conference To Be Webcast
May 3, 2012
|
9.1 KB |
|
| |
SAN DIEGO, May 3, 2012 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that it will be participating in the Deutsche Bank 37th Annual Health Care Conference on Tuesday, Ma...
|
|
Volcano Corporation Reports 12 Percent Increase in First Quarter Revenues
May 2, 2012
|
22.5 KB |
|
| |
SAN DIEGO, May 2, 2012 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today said revenues in the first quarter of 2012 increased 12 percent over the same period a year ago.
F...
|
|
Volcano Corporation Schedules First Quarter Conference Call, Webcast
Apr 23, 2012
|
9.1 KB |
|
| |
SAN DIEGO, April 23, 2012 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced it will report its operating results for the first quarter of fiscal 2012 on Wednesday, May ...
|
|
Volcano Corporation Presentation at Roth Conference to be Webcast
Mar 5, 2012
|
9.0 KB |
|
| |
SAN DIEGO, March 5, 2012 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that it will be participating in the Roth Capital 24th Annual Orange County Growth Stock Conferenc...
|
|
Volcano Reports 14 Percent Increase in Fourth Quarter Revenues; Medical Segment Revenues Grow 20 Percent
Feb 22, 2012
|
26.4 KB |
|
| |
SAN DIEGO, Feb. 22, 2012 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today said revenues in the fourth quarter of 2011 increased 14 percent versus the fourth quarter of 2010.
...
|
|
Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast
Feb 9, 2012
|
9.1 KB |
|
| |
SAN DIEGO, Feb. 9, 2012 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced it will report its operating results for the fourth quarter of fiscal 2011 on Wednesday, Febru...
|
|
Volcano Corporation Announces Preliminary Fourth Quarter 2011 Revenues
Jan 9, 2012
|
13.5 KB |
|
| |
SAN DIEGO, Jan. 9, 2012 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision intravascular diagnosis and therapy guidance tools designed to enhance the treatment of coronary and peripheral artery disease, said today it expects total revenues for the fourth quarter of 2011 will be approximately $92.7 ...
|
|
Volcano Corporation Presentation at J.P. Morgan Conference to be Webcast
Jan 3, 2012
|
9.1 KB |
|
| |
SAN DIEGO, Jan. 3, 2012 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision intravascular diagnosis and therapy guidance tools designed to enhance the treatment of coronary and peripheral vascular disease, said today that it will be participating in the 30th Annual J.P. Morgan Healthcare Conference ...
|
|
Volcano Corporation Announces Presentations at Upcoming Investor Conferences
Nov 22, 2011
|
10.6 KB |
|
| |
SAN DIEGO, Nov. 22, 2011 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision intravascular diagnosis and therapy guidance tools designed to enhance the treatment of coronary and peripheral vascular disease, said today that it will be participating in two upcoming investor conferences.
On Tuesday,...
|
|
ADVISE Study Results Demonstrate the Instant Wave-Free Ratio™, a Vasodilator-Free Measure of Stenosis Severity, is Comparable to FFR
Nov 14, 2011
|
12.8 KB |
|
| |
SAN DIEGO, Nov. 14, 2011 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guidance therapy tools designed to enhance the treatment of coronary and peripheral vascular disease, and Imperial College London jointly announced the results of the ADVISE (ADenosine Vasodilator Independent Stenosis Evalu...
|
|
Upgraded ACCF/ AHA/ SCAI Guidelines Reinforce Benefits of Volcano's Precision Guided Therapy Technologies
Nov 9, 2011
|
11.0 KB |
|
| |
SAN DIEGO, Nov. 9, 2011 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guidance therapy tools designed to enhance the treatment of coronary and peripheral vascular disease, supports the elevation of Intravascular Ultrasound (IVUS) and Fractional Flow Reserve (FFR) technologies in the updated cl...
|
|
Volcano Corporation Announces Upcoming Presentation of Late-Breaking Clinical Trial Results and FFR Product Launch at TCT 2011
Nov 4, 2011
|
13.9 KB |
|
| |
SAN DIEGO, Nov. 4, 2011 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guidance therapy tools designed to enhance the treatment of coronary and peripheral vascular disease, today announced that results from the ADVISE (ADenosine Vasodilator Independent Stenosis Evaluation) clinical trial, spons...
|
|
Volcano Reports 18 Percent Increase in Total Third Quarter Revenues
Oct 31, 2011
|
23.3 KB |
|
| |
SAN DIEGO, Oct. 31, 2011 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision intravascular diagnosis and therapy guidance tools designed to enhance the treatment of coronary and peripheral artery disease, said today that revenues for the third quarter of 2011 increased 18 percent versus the third qu...
|
|
Volcano Corporation Appoints Leslie V. Norwalk and Dr. Eric J. Topol to Board of Directors
Oct 28, 2011
|
10.8 KB |
|
| |
SAN DIEGO, Oct. 28, 2011 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guidance therapy tools designed to enhance the treatment of coronary and peripheral vascular disease, today announced the appointment of Leslie V. Norwalk, Esq., and Eric J. Topol, M.D., to the company's board of directors....
|
|
Volcano Corporation Schedules Third Quarter Conference Call, Webcast
Oct 17, 2011
|
9.1 KB |
|
| |
SAN DIEGO, Oct. 17, 2011 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced that it will report its operating results for the third quarter of fiscal 201...
|
|
Volcano Corporation Announces Presentations at Upcoming Investor Conferences
Sep 1, 2011
|
9.8 KB |
|
| |
SAN DIEGO, Sept. 1, 2011 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision intravascular diagnosis and therapy guidance tools designed to enhance the treatment of coronary and peripheral vascular disease, said today that it will be participating in two upcoming investor conferences.
On Wednesda...
|
|
Volcano Corporation Presentation at Canaccord Genuity Conference to be Webcast
Aug 2, 2011
|
9.0 KB |
|
| |
SAN DIEGO, Aug. 2, 2011 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision intravascular diagnosis and therapy guidance tools designed to enhance the treatment of coronary and peripheral vascular disease, said today that it will be participating in the 2011 Canaccord Genuity Growth Conference on Tu...
|
|
Volcano Reports 22 Percent Increase in Second Quarter Medical Segment Revenues and Earnings per share of $0.09
Aug 1, 2011
|
22.9 KB |
|
| |
SAN DIEGO, Aug. 1, 2011 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision intravascular diagnosis and therapy guidance tools designed to enhance the treatment of coronary and peripheral artery disease, said today that revenues for the second quarter of 2011 increased 14 percent versus the second q...
|
|
|
delicious
Digg
Facebook
LinkedIn
Twitter
Yahoo! Buzz